The genetic background also differed from the training sample and corresponds to tau-related neurodegeneration, the accumulation of which contributes to the pathology of Alzheimer disease (Lasagna-Reeves et al., 2016; Rousseaux et al., 2016; Galasso et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.